-
Loading metrics
Open Access
Peer-reviewed
Research Article
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
-
Phillip C. C. Liu,
Roles Conceptualization, Investigation, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Holly Koblish ,
Roles Conceptualization, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: hkoblish@incyte.com
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Liangxing Wu,
Roles Conceptualization, Investigation
Affiliation Discovery Chemistry, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Kevin Bowman,
Roles Investigation, Methodology, Visualization, Writing – original draft
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Sharon Diamond,
Roles Conceptualization, Supervision
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Darlise DiMatteo,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Yue Zhang,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Michael Hansbury,
Roles Investigation, Writing – original draft
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Mark Rupar,
Roles Investigation, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Xiaoming Wen,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Paul Collier,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Patricia Feldman,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Ronald Klabe,
Roles Investigation, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Krista A. Burke,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Maxim Soloviev,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Christine Gardiner,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Xin He,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Alla Volgina,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Maryanne Covington,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Bruce Ruggeri,
Roles Investigation
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Richard Wynn,
Roles Supervision
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Timothy C. Burn,
Roles Investigation, Supervision
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Peggy Scherle,
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Swamy Yeleswaram,
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Wenqing Yao,
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Discovery Chemistry, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ -
Reid Huber,
Roles Conceptualization
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ - [ ... ],
-
Gregory Hollis
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Discovery Biology, Incyte Research Institute, Wilmington, Delaware, United States of America
⨯ - [ view all ]
- [ view less ]
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
- Phillip C. C. Liu,
- Holly Koblish,
- Liangxing Wu,
- Kevin Bowman,
- Sharon Diamond,
- Darlise DiMatteo,
- Yue Zhang,
- Michael Hansbury,
- Mark Rupar,
- Xiaoming Wen
- Published: April 21, 2020
- https://doi.org/10.1371/journal.pone.0231877